Guy, D. et al. 2021. Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer. Canadian Urological Association Journal. 16, 4 (Nov. 2021), E220–6. DOI:https://doi.org/10.5489/cuaj.7525.